Concepedia
Statistics
Publications
4
Citations
253
H-Index
Active since
2006
Affiliations
Taiho Pharmaceutical (Japan)(Current)
The University of Texas MD Anderson Cancer Center
Center for Cancer and Blood Disorders
Hospital Sírio-Libanês
Keizo Kuwata is an author at Taiho Pharmaceutical (Japan) specializing in oncology, pyrimidine analogues, and cancer pharmacology.
Publications per year
2006–2015
Phase I study to determine the safety and pharmacokinetics of oral administration of TAS‐102 in patients with solid tumors
David S. Hong, James L. Abbruzzese, K. R. Bogaard et al. · Cancer · 2006 · 87 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors
Michael J. Overman, Gauri Varadhachary, Scott Kopetz et al. · Investigational New Drugs · 2008 · 78 citations
Medicine, Oncology, Pharmacology +12
Phase I Clinical Study of Three Times a Day Oral Administration of TAS-102 in Patients with Solid Tumors
Michael J. Overman, Scott Kopetz, Gauri Varadhachary et al. · Cancer Investigation · 2008 · 64 citations
Pharmacy, Oncology, Pharmacotherapy +16
Exposure-dependent incorporation of trifluridine into DNA of tumors and white blood cells in tumor-bearing mouse
Fumiaki Yamashita, Ikumi Komoto, Hiroaki Oka et al. · Cancer Chemotherapy and Pharmacology · 2015 · 24 citations
Medicine, Molecular Biology, Oncology +3
1–4 of 4